Is Sorafenib an Optimal Treatment for Hepatocellular Carcinoma With Macrovascular Invasion or Metastatic Disease?

被引：7
|
作者：
Zhang, Xiu-Ping [1 ]
Wang, Kang [1 ]
Guo, Wei-Xing [1 ]
Chen, Zhen-Hua [1 ]
Cheng, Shu-Qun [1 ]
机构：
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 6, Shanghai, Peoples R China
来源：
HEPATOLOGY | 2018年 / 68卷 / 02期
关键词：
LIVER RESECTION; VEIN INVASION;
D O I：
10.1002/hep.29862
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：786 / 786
页数：1
相关论文
共 50 条
  • [21] Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion
    Munoz-Schuffenegger, Pablo
    Barry, Aisling
    Atenafu, Eshetu G.
    Kim, John
    Brierley, James
    Ringash, Jolie
    Brade, Anthony
    Dinniwell, Robert
    Wong, Rebecca K. S.
    Cho, Charles
    Kim, Tae Kyoung
    Sapisochin, Gonzalo
    Dawson, Laura A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 156 : 120 - 126
  • [22] The effect of apatinib in the treatment of sorafenib resistant metastatic hepatocellular carcinoma A case report
    Han, Zonghong
    He, Zhongming
    Wang, Caoye
    Wang, Qi
    MEDICINE, 2018, 97 (49)
  • [23] Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy
    Inoue, Masanori
    Ogasawara, Sadahisa
    Kobayashi, Kazufumi
    Okubo, Tomomi
    Itokawa, Norio
    Obu, Masamichi
    Fujimoto, Kentaro
    Unozawa, Hidemi
    Yumita, Sae
    Fujiwara, Kisako
    Nakagawa, Miyuki
    Kanzaki, Hiroaki
    Koroki, Keisuke
    Kiyono, Soichiro
    Nakamura, Masato
    Kanogawa, Naoya
    Kondo, Takayuki
    Nakamoto, Shingo
    Nagashima, Kengo
    Itobayashi, Ei
    Atsukawa, Masanori
    Koma, Yoshihiro
    Azemoto, Ryosaku
    Kato, Naoya
    LIVER CANCER, 2024,
  • [24] In patients with hepatocellular carcinoma (HCC) and macrovascular invasion (MVI) amenable to surgical resection, a survival similar to that observed on sorafenib can be achieved
    Costentin, Charlotte E.
    Vibert, Eric
    Roudot-Thoraval, Francoise
    Decaens, Thomas
    Ganne-Carrie, Nathalie
    Paule, Bernard
    Letoublon, Christian
    Chiaradia, Melanie
    Calderaro, Julien
    Adam, Rene
    Bricault, Ivan
    Amaddeo, Giuliana
    Cherqui, Daniel
    Seror, Olivier
    Samuel, Didier
    Mallat, Ariane
    Duvoux, Christophe
    Laurent, Alexis
    HEPATOLOGY, 2015, 62 : 435A - 436A
  • [25] Effectiveness of sorafenib in the treatment of hepatocellular carcinoma
    Salamanca, P.
    Magalhaes, H.
    Carneiro, F.
    Marques, D.
    Faustino, C.
    Sousa, N.
    Machado, M.
    Ferreira, P.
    Raimundo, A.
    Fragoso, M.
    Lara Santos, L.
    Pereira, D.
    ANNALS OF ONCOLOGY, 2016, 27 : 52 - 52
  • [26] Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
    Kane, Robert C.
    Farrell, Ann T.
    Madabushi, Rajanikanth
    Booth, Brian
    Chattopadhyay, Somesh
    Sridhara, Rajeshwari
    Justice, Robert
    Pazdur, Richard
    ONCOLOGIST, 2009, 14 (01): : 95 - 100
  • [27] Sorafenib for the treatment of unresectable hepatocellular carcinoma
    Furuse, Junji
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 779 - 788
  • [28] Sorafenib for the treatment of advanced hepatocellular carcinoma
    Connock, M.
    Round, J.
    Bayliss, S.
    Tubeuf, S.
    Greenheld, W.
    Moore, D.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 17 - 21
  • [29] Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma
    Hee Kyung Ahn
    Soohyeon Lee
    Jong-Mu Sun
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Won Ki Kang
    Ho Yeong Lim
    Investigational New Drugs, 2012, 30 : 1768 - 1772
  • [30] Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma
    Ahn, Hee Kyung
    Lee, Soohyeon
    Sun, Jong-Mu
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Kang, Won Ki
    Lim, Ho Yeong
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1768 - 1772
12345